Filed 9mo ago· Aug 14, 2025
10 days to disclose
Scott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$15K-$50K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–20 of 20
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 9mo ago· Aug 14, 2025
10 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−17.9% vs S&P 500
Trade dateAug 4, 2025
Filed 10mo ago· Jul 14, 2025
28 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+9.4% vs S&P 500
Trade dateJun 16, 2025
Filed 10mo ago· Jul 14, 2025
28 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Merck
MRK
$1K-$15K
+9.4% vs S&P 500
Trade dateJun 16, 2025
Stock
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day windowScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+43.9% vs S&P 500
Trade dateAug 7, 2024
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day windowScott Franklin
RHouseFlorida-18
↑bought
Merck
MRK
$1K-$15K
−0.8% vs S&P 500
Trade dateAug 7, 2024
Stock
Filed 11mo ago· Jul 3, 2025
330 days to disclose · 285 past 45-day windowScott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$1K-$15K
+3.1% vs S&P 500
Trade dateAug 7, 2024
Filed 1.1y ago· Apr 11, 2025
15 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$1K-$15K
−37.2% vs S&P 500
Trade dateMar 27, 2025
Filed 1.1y ago· Apr 11, 2025
15 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Novo Nordisk
NVO
$15K-$50K
−37.2% vs S&P 500
Trade dateMar 27, 2025
Filed 1.8y ago· Aug 20, 2024
13 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$15K-$50K
+43.9% vs S&P 500
Trade dateAug 7, 2024
Filed 1.8y ago· Aug 20, 2024
13 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$50K-$100K
+3.1% vs S&P 500
Trade dateAug 7, 2024
Filed 1.8y ago· Aug 20, 2024
14 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Pfizer
PFE
$15K-$50K
+0.7% vs S&P 500
Trade dateAug 6, 2024
Pfizer, Inc.
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Amgen
AMGN
$1K-$15K
+1.1% vs S&P 500
Trade dateAug 2, 2024
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Merck
MRK
$1K-$15K
Trade dateAug 2, 2024
Stock
Filed 1.8y ago· Aug 20, 2024
18 days to discloseScott Franklin
RHouseFlorida-18
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+47.1% vs S&P 500
Trade dateAug 2, 2024
Filed 2.6y ago· Oct 12, 2023
31 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Merck
MRK
$15K-$50K
+11.7% vs S&P 500
Trade dateSep 11, 2023
Stock
Filed 2.6y ago· Oct 12, 2023
31 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Johnson & Johnson
JNJ
$15K-$50K
+11.7% vs S&P 500
Trade dateSep 11, 2023
Filed 2.6y ago· Oct 12, 2023
31 days to discloseScott Franklin
RHouseFlorida-18
↓sold
Pfizer
PFE
$15K-$50K
+11.7% vs S&P 500
Trade dateSep 11, 2023
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$2K-6.2% −17.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 14, 2025 9mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Aug 4, 2025 10 days to disclose | Bad buy·−$500-6.2% −17.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | Scott Franklin RHouseFlorida-18 | ↓sold | Johnson & Johnson JNJ | Jun 16, 2025 28 days to disclose | Flat·+0.0% +9.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 14, 2025 10mo ago | Scott Franklin RHouseFlorida-18 | ↓sold | Merck MRK Stock | Jun 16, 2025 28 days to disclose | Flat·+0.0% +9.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$3.6K+45.6% +43.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Merck MRK Stock | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$76+1.0% −0.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$386+4.8% +3.1% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Mar 27, 2025 15 days to disclose | Bad buy·−$2.8K-34.8% −37.2% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Novo Nordisk NVO | Mar 27, 2025 15 days to disclose | Bad buy·−$11.3K-34.8% −37.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2024 13 days to disclose | Good buy·+$14.8K+45.6% +43.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 7, 2024 13 days to disclose | Good buy·+$3.6K+4.8% +3.1% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Pfizer PFE Pfizer, Inc. | Aug 6, 2024 14 days to disclose | Flat·+0.0% +0.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Amgen AMGN | Aug 2, 2024 18 days to disclose | Flat·-0.4% +1.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Merck MRK Stock | Aug 2, 2024 18 days to disclose | Bad buy·−$114-1.4% | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 2, 2024 18 days to disclose | Good buy·+$3.6K+45.5% +47.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Merck MRK Stock | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Johnson & Johnson JNJ | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | Scott Franklin RHouseFlorida-18 | ↓sold | Pfizer PFE | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |